While in aHUS, patients following homozygous genetic mutations (most notably complement factor H, CHF) should be given a proper complement blockade as soon as possible, an MCPggaac haplotype compounding with other heterozygous mutations (most notably CHF) is prone to recidivate episodes of aHUS. Here, CFH is linked to congestive heart failure.